{"id":"https://openalex.org/W4400906007","doi":"https://doi.org/10.33696/cancerimmunol.6.087","title":"Tertiary Prevention and Treatment for Reducing Leukemia Relapse","display_name":"Tertiary Prevention and Treatment for Reducing Leukemia Relapse","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4400906007","doi":"https://doi.org/10.33696/cancerimmunol.6.087"},"language":"en","primary_location":{"id":"doi:10.33696/cancerimmunol.6.087","doi":"https://doi.org/10.33696/cancerimmunol.6.087","is_oa":true,"landing_page_url":"https://doi.org/10.33696/cancerimmunol.6.087","pdf_url":"https://www.scientificarchives.com/public/assets/articles/article-pdf-1721760815-1218.pdf","source":{"id":"https://openalex.org/S4387278351","display_name":"Journal of Cancer Immunology","issn_l":"2689-968X","issn":["2689-968X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4323867245","host_organization_name":"Scientific Archives LLC","host_organization_lineage":["https://openalex.org/P4323867245"],"host_organization_lineage_names":["Scientific Archives LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.scientificarchives.com/public/assets/articles/article-pdf-1721760815-1218.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092123047","display_name":"Nikita Manyak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikita Manyak","raw_affiliation_strings":["School of Nursing , University of California , Los Angeles , Los Angeles , CA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Nursing , University of California , Los Angeles , Los Angeles , CA , USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079900226","display_name":"Mingyi Chen","orcid":"https://orcid.org/0000-0001-6754-0480","observed_orcids":["https://orcid.org/0000-0001-6754-0480"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mingyi Chen","raw_affiliation_strings":["Department of Pathology , University of Texas Southwestern Medical Center , Dallas , TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology , University of Texas Southwestern Medical Center , Dallas , TX , USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012046553","display_name":"Su Yon Jung","orcid":"https://orcid.org/0000-0002-0513-1830","observed_orcids":["https://orcid.org/0000-0002-0513-1830"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Su Yon Jung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5012046553"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4161,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.62937458,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"6","issue":"2","first_page":"70","last_page":"76"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leukemia-relapse","display_name":"leukemia relapse","score":0.9190000295639038},{"id":"https://openalex.org/keywords/tertiary-prevention","display_name":"tertiary prevention","score":0.9589999914169312},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9200000166893005},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.7820000052452087},{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.9309999942779541},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tisagenlecleucel","display_name":"tisagenlecleucel","score":0.9210000038146973},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7089999914169312},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.8109999895095825},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9789999723434448},{"id":"https://openalex.org/keywords/l-asparaginase","display_name":"L-asparaginase","score":0.9290000200271606},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7850000262260437}],"concepts":[{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.49639230966567993},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49039530754089355},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37252238392829895},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3322391211986542},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31048569083213806}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.33696/cancerimmunol.6.087","doi":"https://doi.org/10.33696/cancerimmunol.6.087","is_oa":true,"landing_page_url":"https://doi.org/10.33696/cancerimmunol.6.087","pdf_url":"https://www.scientificarchives.com/public/assets/articles/article-pdf-1721760815-1218.pdf","source":{"id":"https://openalex.org/S4387278351","display_name":"Journal of Cancer Immunology","issn_l":"2689-968X","issn":["2689-968X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4323867245","host_organization_name":"Scientific Archives LLC","host_organization_lineage":["https://openalex.org/P4323867245"],"host_organization_lineage_names":["Scientific Archives LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer Immunology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.33696/cancerimmunol.6.087","doi":"https://doi.org/10.33696/cancerimmunol.6.087","is_oa":true,"landing_page_url":"https://doi.org/10.33696/cancerimmunol.6.087","pdf_url":"https://www.scientificarchives.com/public/assets/articles/article-pdf-1721760815-1218.pdf","source":{"id":"https://openalex.org/S4387278351","display_name":"Journal of Cancer Immunology","issn_l":"2689-968X","issn":["2689-968X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4323867245","host_organization_name":"Scientific Archives LLC","host_organization_lineage":["https://openalex.org/P4323867245"],"host_organization_lineage_names":["Scientific Archives LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.550000011920929}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400906007.pdf","grobid_xml":"https://content.openalex.org/works/W4400906007.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4379984757","https://openalex.org/W4401762571","https://openalex.org/W2012003343","https://openalex.org/W1993927318","https://openalex.org/W2003986272","https://openalex.org/W7171773601","https://openalex.org/W1985214589","https://openalex.org/W4415351240","https://openalex.org/W3037299043","https://openalex.org/W1790563890"],"abstract_inverted_index":{"We":[0,21],"have":[1,98,112],"found":[2],"little":[3],"available":[4],"information":[5],"in":[6,116,170],"the":[7,11,29,39,47,58,62,66,177,189],"medical":[8],"literature":[9,26],"on":[10,232],"prevention":[12,155,243],"and":[13,41,54,75,86,91,101,110,118,159],"treatment":[14,76],"of":[15,35,107,156,165,179,211],"tertiary":[16,217,242],"leukemia":[17,79],"or":[18,216,227],"patients'":[19],"prognosis.":[20],"thus":[22],"conducted":[23],"a":[24,119,160,193,199,220,241],"comprehensive":[25],"review":[27],"using":[28,46],"most":[30,190],"recently":[31],"updated":[32],"American":[33],"Society":[34],"Hematology":[36],"guidelines,":[37],"searching":[38],"MEDLINE":[40],"PubMed":[42],"electronic":[43],"databases":[44],"by":[45],"key":[48],"term":[49],"\"progression-free":[50],"survival":[51,122,131,163,223],"(PFS)":[52],"leukemia\"":[53],"restricting":[55],"results":[56],"to":[57,95,140],"English":[59],"language":[60],"within":[61,104],"last":[63],"decade.":[64],"From":[65],"initially":[67],"identified":[68],"1,083":[69],"papers,":[70],"we":[71],"extracted":[72],"relevant":[73],"data":[74],"recommendations":[77],"for":[78,88,208],"patients.":[80],"Standard":[81],"treatments":[82,185],"like":[83],"Daunorubicin,":[84],"Doxorubicin,":[85],"Asparaginase":[87],"children,":[89],"adolescents,":[90],"young":[92],"adults":[93],"(18":[94],"24":[96],"years)":[97],"high":[99],"relapse":[100,151,158],"complication":[102],"rates":[103,115],"5":[105,226],"years":[106],"treatment.":[108],"Blinatumomab":[109],"Ibrutinib-Rituximab":[111],"higher":[113,161],"success":[114],"PFS":[117],"greater":[120],"overall":[121,162],"rate":[123,164,224],"than":[124],"other":[125],"chemotherapy":[126],"options":[127],"have.":[128],"Two-year":[129],"disease-free":[130],"was":[132],"39.0%":[133],"with":[134,142,168,174,219],"intensive":[135],"chemotherapy,":[136],"whereas":[137],"it":[138],"rose":[139],"54.4%":[141],"anticancer":[143],"drugs.":[144],"Additionally,":[145],"patients":[146,171],"who":[147],"underwent":[148],"radiotherapy":[149],"after":[150,214],"exhibited":[152],"better":[153],"long-term":[154],"another":[157],"77.7%":[166],"compared":[167],"11.3%":[169],"not":[172],"treated":[173],"radiotherapy.":[175],"In":[176],"realm":[178],"pediatric":[180,212],"leukemias,":[181],"allogeneic":[182],"stem":[183],"cell":[184],"stand":[186],"out":[187],"as":[188],"effective,":[191],"boasting":[192],"superior":[194],"remission":[195],"rate.":[196],"Notably,":[197],"Tisagenlecleucel,":[198],"chimeric":[200],"antigen":[201],"receptor":[202],"(CAR)":[203],"T-cell":[204],"therapy,":[205],"is":[206,234],"approved":[207],"managing":[209],"relapses":[210],"leukemias":[213],"initial":[215],"remission,":[218],"promising":[221],"50%":[222],"over":[225],"10":[228],"years.":[229],"Further":[230],"study":[231],"immunotherapies":[233],"warranted":[235],"across":[236],"diverse":[237],"age":[238],"groups":[239],"from":[240],"perspective.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-12T09:15:50.089291","created_date":"2024-07-24T00:00:00"}